Suppr超能文献

一项针对宫颈上皮内瘤变女性的队列研究中针对人乳头瘤病毒16型(HPV-16)病毒样颗粒的免疫反应。II. 全身性而非局部性IgA反应与HPV-16清除相关。

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.

作者信息

Bontkes H J, de Gruijl T D, Walboomers J M, Schiller J T, Dillner J, Helmerhorst T J, Verheijen R H, Scheper R J, Meijer C J

出版信息

J Gen Virol. 1999 Feb;80 ( Pt 2):409-417. doi: 10.1099/0022-1317-80-2-409.

Abstract

To investigate whether there is an association between local or systemic IgG and IgA responses against human papillomavirus (HPV) type 16 virus-like particles (VLP) containing L1 and L2 and the possible influence of these responses on clearance of HPV-16 and its associated lesions, cervical mucus samples from 125 patients and plasma samples from 100 patients, all participating in a non-intervention cohort study of women with abnormal cytology, were analysed. The results show that local IgG and IgA HPV-16 VLP-specific antibodies do not correlate with virus clearance. However, systemic IgG responses were more frequently detected in patients with a persistent infection (11/24) compared with patients with cleared HPV-16 infections (3/28, P = 0.006). Furthermore, the ultimate development of high-grade lesions was associated with systemic VLP-specific IgG reactivity (P = 0.026). By contrast, systemic IgA responses were correlated with virus clearance (7/28 clearance compared with 1/24 persistence patients, P = 0.06). This correlation was statistically significant when only those clearance patients who tested HPV-16 DNA-positive at more than one visit were included in the analysis (5/11 compared with 1/24, P = 0.007). As these systemic IgA responses were not accompanied by local IgA responses, the systemic IgA responses in HPV-16 clearance patients are suggested to be a by-product of a successful cellular immune response induced at the local lymph nodes, mediated by cytokines.

摘要

为了研究针对包含L1和L2的人乳头瘤病毒16型(HPV-16)病毒样颗粒(VLP)的局部或全身IgG和IgA反应与这些反应对HPV-16及其相关病变清除的可能影响之间是否存在关联,我们分析了125例患者的宫颈黏液样本和100例患者的血浆样本,所有患者均参与了一项针对细胞学异常女性的非干预队列研究。结果表明,局部IgG和IgA HPV-16 VLP特异性抗体与病毒清除无关。然而,与HPV-16感染已清除的患者(3/28,P = 0.006)相比,持续性感染患者(11/24)中更频繁地检测到全身IgG反应。此外,高级别病变的最终发展与全身VLP特异性IgG反应性相关(P = 0.026)。相比之下,全身IgA反应与病毒清除相关(清除患者中7/28与持续性感染患者中1/24,P = 0.06)。当仅将那些在多次就诊时HPV-16 DNA检测呈阳性的清除患者纳入分析时,这种相关性具有统计学意义(5/11与1/24,P = 0.007)。由于这些全身IgA反应并未伴随局部IgA反应,因此推测HPV-16清除患者中的全身IgA反应是局部淋巴结诱导的成功细胞免疫反应的副产物,由细胞因子介导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验